Randomized controlled clinical trial on the antiseptic efficacy of polihexanide 0.04% on acute traumatic wounds - 20/03/18
Summary |
Prevention of wound infections is a challenge in clinical practice. The aim of this study was to assess the efficacy of polyhexamethylene biguanide (PHMB, polihexanide) 0.04% on acute traumatic wounds. It was a randomized, double-blind, placebo-controlled prospective trial which included 61 patients. The polihexanide group showed a significant decrease in log10 colony-forming units (cfu) (P < 0.001) after 60 min treatment in comparison to baseline cfu, whereas the Ringer solution group did not show a significant change in cfu during 60 min treatment. Treatment of polihexanide 0.04% resulted in a significant reduction of bacterial load in acute traumatic wounds.
El texto completo de este artículo está disponible en PDF.Keywords : Traumatic wounds, Efficacy, Polihexanide, Polyhexamethylene biguanide, Antiseptic
Esquema
| ☆ | Partly presented at the 22nd Conference of the European Wound Management Association, Vienna, Austria, May 23rd–25th, 2012. |
Vol 98 - N° 4
P. 429-432 - avril 2018 Regresar al número
Artículo precedente
- Barriers to implementing the NICE guidelines for early-onset neonatal infection: cross-sectional survey of neonatal blood culture reporting by laboratories in the UK
- S.P. Paul, E.M. Caplan, H.A. Morgan, P.C. Turner
- Surface disinfection challenges for Candida auris: an in-vitro study
- R. Kean, L. Sherry, E. Townsend, E. McKloud, B. Short, A. Akinbobola, W.G. Mackay, C. Williams, B.L. Jones, G. Ramage
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?